ALGS - Aligos Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
9.61 0.77 (8.01%)	---	---	---	---	0.77 (8.01%)	0.17 (1.75%)	0.17 (1.75%)

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.53
Diluted EPS:: -1.53
Basic P/E:: -6.7843
Diluted P/E:: -6.7843
RSI(14) 1m:: 59.43
VWAP:: 10.33
RVol:: 1.4497

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	9.76 +0.11 (+1.14%)	Oct 15 09:43
1m	Price increase 1m	9.84 +0.23 (+2.39%)	Oct 15 09:42
10m	Price increase 10m	9.84 +0.38 (+4.07%)	Oct 15 09:42